300298 Stock Overview
Engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Sinocare Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥27.27 |
| 52 Week High | CN¥33.28 |
| 52 Week Low | CN¥19.19 |
| Beta | 0.19 |
| 11 Month Change | 20.61% |
| 3 Month Change | 7.62% |
| 1 Year Change | 6.27% |
| 33 Year Change | 15.89% |
| 5 Year Change | 100.51% |
| Change since IPO | 334.06% |
Recent News & Updates
Sinocare Inc.'s (SZSE:300298) Price Is Out Of Tune With Earnings
Aug 07
Calculating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)
Jul 19Recent updates
Sinocare Inc.'s (SZSE:300298) Price Is Out Of Tune With Earnings
Aug 07Calculating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)
Jul 19Is Sinocare (SZSE:300298) A Risky Investment?
Jun 07Sinocare's (SZSE:300298) Soft Earnings Don't Show The Whole Picture
May 02Sinocare Inc.'s (SZSE:300298) P/E Is On The Mark
Apr 22Here's What To Make Of Sinocare's (SZSE:300298) Decelerating Rates Of Return
Apr 03Shareholder Returns
| 300298 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 15.5% | 5.8% | 9.6% |
| 1Y | 6.3% | -17.1% | -12.3% |
Return vs Industry: 300298 exceeded the CN Medical Equipment industry which returned -17.1% over the past year.
Return vs Market: 300298 exceeded the CN Market which returned -12.3% over the past year.
Price Volatility
| 300298 volatility | |
|---|---|
| 300298 Average Weekly Movement | 6.3% |
| Medical Equipment Industry Average Movement | 5.3% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.4% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 300298 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300298's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 4,737 | Shao Bo Li | www.sinocare.com |
Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers SARS-CoV-2 antibody test strips; blood glucose monitors; bi-functional blood glucose monitors; point of care testing products; digital management tool solutions; non-invasive screening products; diabetes peripheral products; and PTS and Trividia Products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals.
Sinocare Inc. Fundamentals Summary
| 300298 fundamental statistics | |
|---|---|
| Market cap | CN¥14.05b |
| Earnings (TTM) | CN¥306.51m |
| Revenue (TTM) | CN¥4.18b |
49.3x
P/E Ratio3.6x
P/S RatioIs 300298 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300298 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.18b |
| Cost of Revenue | CN¥1.86b |
| Gross Profit | CN¥2.32b |
| Other Expenses | CN¥2.01b |
| Earnings | CN¥306.51m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.55 |
| Gross Margin | 55.46% |
| Net Profit Margin | 7.32% |
| Debt/Equity Ratio | 26.2% |
How did 300298 perform over the long term?
See historical performance and comparison